Calcitonin-induced NF-κB activation up-regulates fibronectin expression in MG63 osteosarcoma cells

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 4901-4906

  Tsagaraki, Ioanna ^a   Phenekos, Constantinos ^b   Tsilibary, Effie ^a   Tzinia, Athina ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

Calcitonin; Fibronectin; Integrins; Matrix metalloproteinase 9; MG63 cells; NF B activation

Indexed keywords

CALCITONIN; FIBRONECTIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN RECEPTOR; INTERSTITIAL COLLAGENASE; PROTEIN SERINE THREONINE KINASE; SERINE; THREONINE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL INTERACTION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CALCITONIN; FIBRONECTIN; INTEGRINS; MATRIX METALLO-PROTEINASE 9; MG63 CELLS; NF-ΚB ACTIVATION;

ADULT; AGED; BLOTTING, WESTERN; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CALCITONIN; CELL PROLIFERATION; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NF-KAPPA B; OSTEOSARCOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84891357264     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sabbisetti VS, Chirugupati S, Thomas S, Vaidya KS, Reardon D, Chiriva-Internati M, Iczkowski KA and Shah GV: Calcitonin increases invasiveness of prostate cancer cells: Role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer 117: 551-560, 2005.
2. Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I and Kakudo K: Calcitonin inhibits invasion of breast cancer cells: Involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Int J Oncol 28: 807-814 2006.
3. Zaidi M, Inzerillo AM, Moonga BS, Bevis PJ and Huang CL: Forty years of calcitonin - where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30: 655-663, 2002.
4. Horne WC, Shyu JF, Chakraborty M and Baron R: Signal transduction by calcitonin Multiple ligands, receptors, and signaling pathways. Trends Endocrinol Metab 5: 395-401, 1994.
5. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, Tankó LB, Bagger YZ, Christiansen C and Karsdal MA: Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis cartilage 14: 759-768, 2006.
6. Tang CH, Yang RS, Chen YF and Fu WM: Basic fibroblast growth factor stimulates fibronectin expression through phospholipase C gamma, protein kinase C alpha, c-Src, NF-κB, and p300 pathway in osteoblasts. J Cell Physiol 211: 45-55, 2007.
7. Han SW and Roman J: Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: Prooncogenic effects mediated by PI3-kinase and NF-κB. Oncogene. 25: 4341-4349, 2006.
8. Jia D, Yan M, Wang X, Hao X, Liang L, Liu L, Kong H, He X, Li J and Yao M: Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC cancer 10: 364, 2010.
9. Han S, Ritzenthaler JD, Sitaraman SV and Roman J: Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281: 29614-29624, 2006.
10. Nagase H, Visse R and Murphy G: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573, 2006.
11. Tsagaraki I, Tsilibary EC and Tzinia AK. TIMP-1 interaction with αvκ3 integrin confers resistance to human osteosarcoma cell lineMG-63 against TNF-α-induced apoptosis. Cell Tissue Res 3421:87-96, 2010.
12. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
13. Farley JR, Wergedal JE, Hall SL, Herring S and Tarbaux NM: Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells. Calcif Tissue Int 48: 297-301, 1991.
14. Yu XJ, Li CY, Xu YH, Chen LM and Zhou CL: Calcitonin gene-related peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases. Cell Biol Int 33:1144-1148, 2009.
15. Jin YJ, Park I, Hong IK, Byun HJ, Choi J, Kim YM and Lee H: Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)κ(1)/α(v)κ(3)-dependent AKT, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell Signal 23: 125-134, 2011.
16. Traynor K: Experts recommend against calcitonin-salmon for postmenopausal osteoporosis. Am J Health Syst Pharm 70: 648, 650, 2013.
17. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC and Bellido T: Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374, 1999.
18. Findlay DM: Regulation of cell growth mediated by the calcitonin receptor. Cell Mol Biol (Noisy-le-grand) 52: 3-8, 2006.
19. Li XW, Hu CP, Wu WH, Zhang WF, Zou XZ and Li YJ: Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. Eur J Pharmacol 679: 117-126, 2012.
20. Mapp PI, McWilliams DF, Turley MJ, Hargin E and Walsh DA: A role for the sensory neuropeptide calcitonin gene-related peptide in endothelial cell proliferation in vivo. Br J Pharmacol 166: 1261-1271, 2012.
21. Semplicini A, Ceolotto G, Baritono E, Malendowicz LK, Andreis PG, Sartori M, Rossi GP and Nussdorfer GG: Adrenomedullin stimulates DNA synthesis of rat adrenal zona glomerulosa cells through activation of the mitogen-activated protein kinase-dependent cascade. J Hypertens 19: 599-602, 2001.
22. Uzan B, Villemin A, Garel JM and Cressent M: Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway. J Cell Physiol 215: 122-128, 2008.
23. Thomas S and Shah G: Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the AKT/survivin pathway. Cancer Biol Ther 4: 1226-1233, 2005.
24. Nakamura M, Han B, Nishishita T, Bai Y and Kakudo K: Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers. J Mol Endocrinol 39: 375-384, 2007.
25. Ishikawa Y, Wu LN, Genge BR, Mwale F and Wuthier RE: Effects of calcitonin and parathyroid hormone on calcification of primary cultures of chicken growth plate chondrocytes. J Bone Miner Res 12: 356-366, 1997.
26. Xin X, Khan ZA, Chen S and Chakrabarti S: Glucose-induced AKT1 activation mediates fibronectin synthesis in endothelial cells. Diabetologia 48: 2428-2436, 2005.
27. Zeng BX, Fujiwara H, Sato Y, Nishioka Y, Yamada S, Yoshioka S, Ueda M, Higuchi T and Fujii S: Integrin α5 is involved infibronectin-induced human extravillous trophoblast invasion. J Reprod Immunol 73: 1-10, 2007.
28. Cheng T, Zhang L, Fu X, Wang W, Xu H, Song H and Zhang Y: The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis. Connect Tissue Res 54: 139-146, 2013.
29. Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A, Noguchi T and Hayakawa T: Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS lett 396: 103-107, 1996.
30. Sil H, Sen T and Chatterjee A: Fibronectin-integrin (α5κ1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9. Oncol Res 19: 335-348, 2011.
31. Xiong T, Zhao Y, Hu D, Meng J, Wang R, Yang X, Ai J, Qian K and Zhang H: Administration of calcitonin promotes blastocyst implantation in mice by up-regulating integrin α3 expression inendometrial epithelial cells. Hum Reprod 27: 3540-3551, 2012.